Scalper1 News
The push for U.S. companies to move overseas kept investors busy Monday as Mylan (MYL) agreed to buy part of Abbott Laboratories’ (ABT) generic-drug business and relocate to the Netherlands, sending its stock up nearly 3% on the stock market. Meanwhile, Abbott’s former proprietary-drug unit AbbVie (ABBV) revised its bid for Britain’s Shire (SHPG) again after the latter finally came to the bargaining table. Abbott will hang on to its branded Scalper1 News
Scalper1 News